These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27152771)

  • 1. Modulation of Amyloid Aggregates into Nontoxic Coaggregates by Hydroxyquinoline Appended Polyfluorene.
    Chowdhury SR; Agarwal M; Meher N; Muthuraj B; Iyer PK
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13309-19. PubMed ID: 27152771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation.
    Zhu L; Song Y; Cheng PN; Moore JS
    J Am Chem Soc; 2015 Jul; 137(25):8062-8. PubMed ID: 26043045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
    Son G; Lee BI; Chung YJ; Park CB
    Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
    Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
    ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
    Suganthy N; Sheeja Malar D; Pandima Devi K
    Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the inhibitory potential of Vitamin A against fibrillation and amyloid associated cytotoxicity.
    Alam P; Siddiqi MK; Malik S; Chaturvedi SK; Uddin M; Khan RH
    Int J Biol Macromol; 2019 May; 129():333-338. PubMed ID: 30738899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases.
    Alam P; Chaturvedi SK; Siddiqi MK; Rajpoot RK; Ajmal MR; Zaman M; Khan RH
    Sci Rep; 2016 May; 6():26759. PubMed ID: 27230476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies to prevent Alzheimer's disease pathogenesis using a fluorescent conjugated polyelectrolyte.
    Dwivedi AK; Iyer PK
    Macromol Biosci; 2014 Apr; 14(4):508-14. PubMed ID: 23836416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer.
    Nie RZ; Zhu W; Peng JM; Ge ZZ; Li CM
    Biochimie; 2016 Jun; 125():204-12. PubMed ID: 27079519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling the inhibitory and cytoprotective potential of diuretics towards amyloid fibrillation.
    Malik S; Siddiqi MK; Majid N; Masroor A; Moasfar Ali S; Khan RH
    Int J Biol Macromol; 2020 May; 150():1258-1271. PubMed ID: 31743708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foldamer-Mediated Structural Rearrangement Attenuates Aβ Oligomerization and Cytotoxicity.
    Kumar S; Henning-Knechtel A; Chehade I; Magzoub M; Hamilton AD
    J Am Chem Soc; 2017 Nov; 139(47):17098-17108. PubMed ID: 29058422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
    Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remarkably Efficient Blood-Brain Barrier Crossing Polyfluorene-Chitosan Nanoparticle Selectively Tweaks Amyloid Oligomer in Cerebrospinal Fluid and Aβ1-40.
    Roy Chowdhury S; Mondal S; Muthuraj B; Balaji SN; Trivedi V; Krishnan Iyer P
    ACS Omega; 2018 Jul; 3(7):8059-8066. PubMed ID: 30087934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graphene quantum dots for the inhibition of β amyloid aggregation.
    Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
    Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.